Tesla has canceled the Plaid Plus version of the Model S, the most expensive variant of its flagship sedan, for being just too good, according to CEO Elon Musk.
“Plaid+ is canceled. No need, as Plaid is just so good.” Musk twitted.
The tri-motor Plaid Plus was supposed to deliver 1,100 horsepower, 520 miles of range on a fully charged battery, and acceleration from 0 to 60 mph in less than two seconds.
Like other North American automakers, Tesla has been grappling with a computer chip shortage and other supply chain issues.
In March, the price of the Plaid Plus was increased by $10,000 to bring it to about $150,000. By the last week of May, Tesla removed the option to order the Model S Plaid Plus variant from its website.
The remaining high-end version of the Model S Plaid will cost around $119,900 and feature a 390-mile range battery, with 1,020 horsepower and acceleration from 0 to 60 miles per hour in two seconds, among other features.
Tesla has been grappling with supply chain issues especially a computer chip shortage, just like other automakers.
It was forced to remove radar sensors and lumbar support from the front passenger seats in its lower-priced Model 3 sedan and Model Y crossover for customers in North America.
Tesla did not produce any of its higher-priced Model S or Model X vehicles in the first quarter, even though Musk had said production was underway in the fourth quarter of last year.


BOJ Governor Signals Gradual Rate Hikes as Japan’s Inflation Nears 2% Target
Taiwan Stock Market Ends Higher as Semiconductor and Energy Shares Lead Gains
Wall Street Ends Higher as S&P 500, Nasdaq Extend Gains Ahead of Holiday Week
Global Demand for Yuan Loans and Bonds Surges as China Pushes Currency Internationalization
Why U.S. Coffee Prices Are Staying High Despite Trump’s Tariff Rollbacks
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
FDA Approves Mitapivat for Anemia in Thalassemia Patients
US and Japan Fast-Track $550 Billion Strategic Investment Initiative
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



